1. Home
  2. HOWL vs IROH Comparison

HOWL vs IROH Comparison

Compare HOWL & IROH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • IROH
  • Stock Information
  • Founded
  • HOWL 2017
  • IROH 2021
  • Country
  • HOWL United States
  • IROH United States
  • Employees
  • HOWL N/A
  • IROH N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • IROH
  • Sector
  • HOWL Health Care
  • IROH
  • Exchange
  • HOWL Nasdaq
  • IROH Nasdaq
  • Market Cap
  • HOWL 87.4M
  • IROH 91.2M
  • IPO Year
  • HOWL 2021
  • IROH 2023
  • Fundamental
  • Price
  • HOWL $1.36
  • IROH $10.38
  • Analyst Decision
  • HOWL Strong Buy
  • IROH
  • Analyst Count
  • HOWL 2
  • IROH 0
  • Target Price
  • HOWL $9.50
  • IROH N/A
  • AVG Volume (30 Days)
  • HOWL 263.3K
  • IROH 44.0K
  • Earning Date
  • HOWL 03-06-2025
  • IROH 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • IROH N/A
  • EPS Growth
  • HOWL N/A
  • IROH N/A
  • EPS
  • HOWL N/A
  • IROH 0.20
  • Revenue
  • HOWL $3,386,000.00
  • IROH N/A
  • Revenue This Year
  • HOWL N/A
  • IROH N/A
  • Revenue Next Year
  • HOWL $34.17
  • IROH N/A
  • P/E Ratio
  • HOWL N/A
  • IROH $53.07
  • Revenue Growth
  • HOWL N/A
  • IROH N/A
  • 52 Week Low
  • HOWL $1.26
  • IROH $9.97
  • 52 Week High
  • HOWL $8.19
  • IROH $11.11
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • IROH N/A
  • Support Level
  • HOWL $1.26
  • IROH N/A
  • Resistance Level
  • HOWL $1.45
  • IROH N/A
  • Average True Range (ATR)
  • HOWL 0.09
  • IROH 0.00
  • MACD
  • HOWL 0.02
  • IROH 0.00
  • Stochastic Oscillator
  • HOWL 45.45
  • IROH 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About IROH Iron Horse Acquisitions Corp. Common Stock

Iron Horse Acquisitions Corp is a blank check company.

Share on Social Networks: